Clinical significance of the expression of activin A in esophageal carcinoma

  • Authors:
    • Keiji Yoshinaga
    • Koshi Mimori
    • Keishi Yamashita
    • Tohru Utsunomiya
    • Hiroshi Inoue
    • Masaki Mori
  • View Affiliations

  • Published online on: January 1, 2003     https://doi.org/10.3892/ijo.22.1.75
  • Pages: 75-80
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Activin A is a member of the transforming growth factor β (TGF-β) superfamily and is a strong differentiation factor of embryonic stem (ES) cells. It is unknown whether activin A has any correlation with carcinoma cell differentiation. We investigated the expression of activin-βA (Act-βA) which is a subunit of activin A, its receptor type I and IIb (ActRI, ActRIIb) and its inhibitor, inhibin-α (Inh-α), which is a subunit of inhibin A in esophageal carcinoma by reverse transcription polymerase chain reaction (RT-PCR) method. Act-βA was overexpressed in carcinoma tissues significantly (p=0.030). On the other hand, Inh-α, ActRI and ActRIIb were neither overexpressed, nor suppressed. In immunohistochemistry and in situ hybridization analysis, Act-βA expression was mainly derived from carcinoma cells. The mRNA expression of Act-βA was not associated with carcinoma cell differentiation but lymph node metastasis (n0, 1, 2 vs. n3, 4; p=0.013) and clinical stage (I, II, III vs. IV; p=0.026). Moreover, patients with high mRNA expression of Act-βA had a tendency to show poor prognosis compared to those with low mRNA expression (p=0.064). The finding indicated that activin A expression might not be associated with carcinoma cell differentiation but tumor aggressiveness such as lymph node metastasis in esophageal carcinoma.

Related Articles

Journal Cover

January 2003
Volume 22 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yoshinaga, K., Mimori, K., Yamashita, K., Utsunomiya, T., Inoue, H., & Mori, M. (2003). Clinical significance of the expression of activin A in esophageal carcinoma. International Journal of Oncology, 22, 75-80. https://doi.org/10.3892/ijo.22.1.75
MLA
Yoshinaga, K., Mimori, K., Yamashita, K., Utsunomiya, T., Inoue, H., Mori, M."Clinical significance of the expression of activin A in esophageal carcinoma". International Journal of Oncology 22.1 (2003): 75-80.
Chicago
Yoshinaga, K., Mimori, K., Yamashita, K., Utsunomiya, T., Inoue, H., Mori, M."Clinical significance of the expression of activin A in esophageal carcinoma". International Journal of Oncology 22, no. 1 (2003): 75-80. https://doi.org/10.3892/ijo.22.1.75